Design, Synthesis, and Biological Evaluation of Subunit-Selective N-Methyl-D-Aspartate Receptor Antagonists Open Access
Mosley, Cara Amelia (2009)
Abstract
Abstract
Design, Synthesis, and Biological Evaluation of
Subunit-Selective
N-Methyl-D-Aspartate Receptor Antagonists
      Part 1: Design, Synthesis, and Biological Evaluation of Novel
NR1/NR2B-Selective NMDA
      
      Receptor Antagonists Towards the Treatment of Neurodegenerative
Diseases
      
      Part 2: Design, Synthesis, and Biological Evaluation of
First-in-Class NR2C/2D-Selective
      
      NMDA Receptor Antagonists
      
      
By Cara A. Mosley
      
Part 1:
N-Methyl-D-Aspartate (NMDA)-selective glutamate receptors are
ligand-gated ion channels that mediate a Ca2+-permeable component
of excitatory
synaptic transmission in the central nervous system. The receptors
are tetrameric
complexes, of which there are four different subtypes (NR2A, NR2B,
NR2C and NR2D). Over-activation of NMDA
receptors has been associated with a number of neurodegenerative
diseases in both
animal and human models including stroke, traumatic brain injury,
epilepsy,
schizophrenia, and neuropathic pain. As a potential treatment for
these disorders, a
number of NMDA receptor antagonists have been developed.
In Chapter 1, the synthesis and structure activity relationship
analysis of novel
enantiomeric propanolamines are presented. Compounds have been
evaluated for
potency against the NR1/NR2B subunit of the N-Methyl-D-Aspartate
(NMDA) receptor.
In addition, the pH sensitivity (fold shift) of the analogues is
discussed. Fold shift, i.e. the
    
increased potency of a given compound at more acidic pH values,
is hypothesized to be
beneficial under ischemic conditions associated with stroke. In
addition, the
compounds described have been specifically designed to exhibit
decreased off-target
activity at the human-ether-a-go-go related gene (hERG) ion
channel, which is often
associated with cardiotoxicity in vivo.
      
In Chapter 2, a novel series of amide-based NR1/NR2B-selective NMDA
receptor
antagonists is described. Originating in a screening hit
characterized by a
thiosemicarbazide linker region, development of structure activity
relationships led to a
novel series of antagonists characterized by an amide scaffold.
Analogue design is targeted towards inducing pH
sensitivity and eliminating off-target effects. Some of the studied
compounds are
potent, selective, non-competitive, and voltage-independent
antagonists of NR2B-
containing NMDA receptors. Like the founding member of this class
of antagonists
(ifenprodil), several interesting compounds of the series bind to
the amino terminal
domain of the NR2B subunit to inhibit function. Analogue potency is
modulated by
    
Table of Contents
    TABLE OF CONTENTS
    
    
    List of Illustrations
    
    
    Figures
    
    
    
    Tables
    
    
    Schemes
    
    
    Graphs
    
    
    Charts
    
    
      
List of Abbreviations
      
      Part 1: Design, Synthesis, and Biological Evaluation of Novel
NR1/NR2B-
Selective NMDA Receptor Antagonists Towards Treatment of
Neurodegenerative Diseases
    
    
    CHAPTER 1
    
    1
    
    1.1 STATEMENT OF PURPOSE
    
    1
    
    1.2 INTRODUCTION AND BACKGROUND
    
    4
    
    1.3 SYNTHESIS OF ENANTIOMERIC PROPANOLAMINE ANALOGUES
    
    31
    
    1.4 PKA DETERMINATION OF NMDA RECEPTOR CHANNEL
BLOCKERS
    
    34
    
    1.5 RESULTS AND DISCUSSION
    
    38
    
    1.6 CHEMISTRY EXPERIMENTAL DETAIL
    
    45
    
    1.7 BIOLOGY EXPERIMENTAL DETAIL
    
    57
    
    
    CHAPTER 2
    
    68
    
    2.1 STATEMENT OF PURPOSE
    
    68
    
    2.2 INTRODUCTION AND BACKGROUND
    
    70
    
    2.3 SYNTHESIS OF HYDRAZIDE-BASED ANALOGUES
    
    77
    
    2.4 BIOLOGICAL EVALUATION OF HYDRAZIDE-BASED ANALOGUES
    
    85
    
    2.5 CONCLUSIONS REGARDING HYDRAZIDE-BASED ANALOGUES
    
    93
    
    2.6 RATIONALE FOR PROPSOSED AMIDE-BASED ANALOGUES
    
    95
    
    2.7 SYNTHESIS OF AMIDE-BASED ANALOGUES
    
    101
    
    2.8 RESULTS AND DISCUSSION
    
    115
    
    2.9 CONCLUSIONS
    
    159
    
    
     Document Outline 
    
- Distribution Agreement
- Signature sheet
- Abstractcoverpage
- thesisabstract_111609
- thesiscoverpage
- TABLE OF CONTENTs_111809 final
- List of Illustrations 111809 final
- List of Abbreviations
- Mosley Thesis Chapter 1_111709_b
- Mosley Thesis_Chapter 2_111709
- Mosley_Thesis_Chapter3_111809
About this Dissertation
| School | |
|---|---|
| Department | |
| Degree | |
| Submission | |
| Language | 
 | 
| Research Field | |
| Keyword | |
| Committee Chair / Thesis Advisor | |
| Committee Members | 
Primary PDF
| Thumbnail | Title | Date Uploaded | Actions | 
|---|---|---|---|
|  | Design, Synthesis, and Biological Evaluation of Subunit-Selective N-Methyl-D-Aspartate Receptor Antagonists () | 2018-08-28 13:11:00 -0400 |  | 
Supplemental Files
| Thumbnail | Title | Date Uploaded | Actions | 
|---|